(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIKARDA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIKARDA

ST13

US500000098559551

Class

5, 40

Filing

98559551

Registration

7783457

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

05/07/2025

Trademark type

Word

Nice classes

5, 40

Filing date

05/20/2024

Registration date

05/06/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/06/2025

Last transaction

05/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

12/13/2022

First use in commerce

12/13/2022

Drawing code

4

Owner type

16

Owner location

Kansas City, MO

Examiner

CREEF, DAVIS

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Likarda, LLC

Representatives

C. Blair Barbieri HOVEY WILLIAMS LLP

Technical classification

Nice Classes

Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Injectable gels in the nature of a hydrogel microbead solution for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of a hydrogel microbead solution for medical purposes used as a drug delivery agent that facilitates the delivery of a wide range of pharmaceuticals; Injectable gels in the nature of a hydrogel microbead solution with stem cellsadult differentiated cellsbiologicsproteinspeptidesantibodiesextracellular vesiclespiezo-emitting biological productscell clustersorganoidscell-based tissuessmall molecule biological products for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of a hydrogel microbead solution with stem cellsadult differentiated cellsbiologicsproteinspeptidesantibodiesextracellular vesiclespiezo-emitting biological productscell clustersorganoidscell-based tissuessmall molecule biological products for medical purposes used as a drug delivery agent that facilitates the delivery of a wide range of pharmaceuticals; Injectable gels in the nature of bulk hydrogel solutions for medical purposes used for viscosupplementation for the treatment of osteoarthritis; Injectable gels in the nature of bulk hydrogel solutions for medical purposes used as a drug delivery agent that facilitate the delivery of a wide range of pharmaceuticals; Medical preparationscellbased tissues and cell clusters for human health and veterinary organ transplantation

Class 40

Custom manufacturing services for others in the fields of pharmaceuticalscosmeticsveterinary preparationsfeaturing encapsulation and injectable hydrogel drug delivery systems for pharmaceutical drugs and biologics

Publications

History of USPTO decisions and trademark events.

19 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/06/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/18/2025

PUBO

PUBLISHED FOR OPPOSITION

03/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/20/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/22/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/22/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/22/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/06/2024

GNRT

NON-FINAL ACTION E-MAILED

12/06/2024

CNRT

NON-FINAL ACTION WRITTEN

12/06/2024

DOCK

ASSIGNED TO EXAMINER

12/04/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/25/2024

NWAP

NEW APPLICATION ENTERED

05/20/2024

Continuous trademark protection

Get notified about every new filing that threatens LIKARDA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.